Literature DB >> 16567401

Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.

Valérie Laurent-Matha1, Danielle Derocq, Christine Prébois, Nobuhiko Katunuma, Emmanuelle Liaudet-Coopman.   

Abstract

The current mechanism proposed for the processing and activation of the 52 kDa lysosomal aspartic protease cathepsin D (cath-D) is a combination of partial auto-activation generating a 51 kDa pseudo-cath-D, followed by enzyme-assisted maturation involving cysteine and/or aspartic proteases and yielding successively a 48 kDa intermediate and then 34 + 14 kDa cath-D mature species. Here we have investigated the in vivo processing of human cath-D in a cath-D-deficient fibroblast cell line in order to determine whether its maturation occurs through already active cath-D and/or other proteases. We demonstrate that cellular cath-D is processed in a manner independent of its catalytic function and that auto-activation is not a required step. Moreover, the cysteine protease inhibitor E-64 partially blocks processing, leading to accumulation of 52-48 kDa cath-D intermediates. Furthermore, two inhibitors, CLICK148 and CA-074Met, specific for the lysosomal cath-L and cath-B cysteine proteases induce accumulation of 48 kDa intermediate cath-D. Finally, maturation of endocytosed pro-cath-D is also independent of its catalytic function and requires cysteine proteases. We therefore conclude that the mechanism of cath-D maturation involves a fully-assisted processing similar to that of pro-renin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567401      PMCID: PMC2376303          DOI: 10.1093/jb/mvj037

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  37 in total

1.  Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro.

Authors:  Ales Premzl; Valentina Zavasnik-Bergant; Vito Turk; Janko Kos
Journal:  Exp Cell Res       Date:  2003-02-15       Impact factor: 3.905

2.  CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.

Authors:  Metwally Montaser; Gilles Lalmanach; Lukas Mach
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

Review 3.  Processing and activation of lysosomal proteinases.

Authors:  Kazumi Ishidoh; Eiki Kominami
Journal:  Biol Chem       Date:  2002-12       Impact factor: 3.915

4.  Structural evidence for gene duplication in the evolution of the acid proteases.

Authors:  J Tang; M N James; I N Hsu; J A Jenkins; T L Blundell
Journal:  Nature       Date:  1978-02-16       Impact factor: 49.962

5.  Intramolecular activation of porcine pepsinogen.

Authors:  M Bustin; A Conway-Jacobs
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

6.  A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

Authors:  M Glondu; P Coopman; V Laurent-Matha; M Garcia; H Rochefort; E Liaudet-Coopman
Journal:  Oncogene       Date:  2001-10-18       Impact factor: 9.867

7.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

8.  Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells.

Authors:  Aline Wille; Annegret Gerber; Anke Heimburg; Anita Reisenauer; Christoph Peters; Paul Saftig; Thomas Reinheckel; Tobias Welte; Frank Bühling
Journal:  Biol Chem       Date:  2004-07       Impact factor: 3.915

9.  A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells.

Authors:  Sanna Partanen; Stephan Storch; Hans-Gerhard Löffler; Andrej Hasilik; Jaana Tyynelä; Thomas Braulke
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

10.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth.

Authors:  Valérie Laurent-Matha; Sharon Maruani-Herrmann; Christine Prébois; Mélanie Beaujouin; Murielle Glondu; Agnès Noël; Marie Luz Alvarez-Gonzalez; Sylvia Blacher; Peter Coopman; Stephen Baghdiguian; Christine Gilles; Jadranka Loncarek; Gilles Freiss; Françoise Vignon; Emmanuelle Liaudet-Coopman
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

View more
  53 in total

1.  Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancer.

Authors:  Evette S Radisky
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis.

Authors:  Gaurav Sharma; Carlos M Guardia; Ajit Roy; Alex Vassilev; Amra Saric; Lori N Griner; Juan Marugan; Marc Ferrer; Juan S Bonifacino; Melvin L DePamphilis
Journal:  Autophagy       Date:  2019-03-08       Impact factor: 16.016

4.  Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.

Authors:  Dhivya R Sudhan; Maria B Rabaglino; Charles E Wood; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2016-04-07       Impact factor: 5.150

5.  Progranulin Stimulates the In Vitro Maturation of Pro-Cathepsin D at Acidic pH.

Authors:  Victoria J Butler; Wilian A Cortopassi; Andrea R Argouarch; Sam L Ivry; Charles S Craik; Matthew P Jacobson; Aimee W Kao
Journal:  J Mol Biol       Date:  2019-01-25       Impact factor: 5.469

6.  Heterologous expression and characterization of the aspartic endoprotease Pep4um from Ustilago maydis, a homolog of the human Chatepsin D, an important breast cancer therapeutic target.

Authors:  Margarita Juárez-Montiel; Pedro Tesillo-Moreno; Ana Cruz-Angeles; Valentina Soberanes-Gutiérrez; Griselda Chávez-Camarillo; J Antonio Ibarra; César Hernández-Rodríguez; Lourdes Villa-Tanaca
Journal:  Mol Biol Rep       Date:  2018-08-03       Impact factor: 2.316

7.  Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model.

Authors:  Dhivya R Sudhan; Christine Pampo; Lori Rice; Dietmar W Siemann
Journal:  Int J Cancer       Date:  2016-02-05       Impact factor: 7.396

Review 8.  The role of Rab GTPases in the pathobiology of Parkinson' disease.

Authors:  Luis Bonet-Ponce; Mark R Cookson
Journal:  Curr Opin Cell Biol       Date:  2019-05-01       Impact factor: 8.382

9.  Changes in Proteases, Antiproteases, and Bioactive Proteins From Mother's Breast Milk to the Premature Infant Stomach.

Authors:  Veronique Demers-Mathieu; Søren Drud Nielsen; Mark A Underwood; Robyn Borghese; David C Dallas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-02       Impact factor: 2.839

10.  Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment.

Authors:  Alina Macovei; Catalina Petrareanu; Catalin Lazar; Paula Florian; Norica Branza-Nichita
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.